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Abstract: Background: Cancer stem cells’ (CSCs) self-maintenance is regulated via the pluripotency
pathways promoting the most aggressive tumor phenotype. This study aimed to use the activity of
these pathways for the CSCs’ subpopulation enrichment and separating cells characterized by the
OCT4 and SOX2 expression. Methods: To select and analyze CSCs, we used the SORE6x lentiviral
reporter plasmid for viral transduction of colon adenocarcinoma cells. Additionally, we assessed
cell chemoresistance, clonogenic, invasive and migratory activity and the data of mRNA-seq and
intrinsic disorder predisposition protein analysis (IDPPA). Results: We obtained the line of CSClike cells selected on the basis of the expression of the OCT4 and SOX2 stem cell factors. The
enriched CSC-like subpopulation had increased chemoresistance as well as clonogenic and migration
activities. The bioinformatic analysis of mRNA seq data identified the up-regulation of pluripotency,
development, drug resistance and phototransduction pathways, and the downregulation of pathways
related to proliferation, cell cycle, aging, and differentiation. IDPPA indicated that CSC-like cells
are predisposed to increased intrinsic protein disorder. Conclusion: The use of the SORE6x reporter
construct for CSCs enrichment allows us to obtain CSC-like population that can be used as a model
to search for the new prognostic factors and potential therapeutic targets for colon cancer treatment.
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1. Introduction
Colon cancer remains one of the most frequent cancers in the developed countries,
following lung and prostate cancers among males, and breast cancer among females [1].
Despite the availability of a wide range of drugs, the disease at the IV metastatic stage
remains incurable, and the five-year survival of these patients does not exceed 5–10% [2,3].
Therefore, the study of malignant tumors in order to find new therapeutic targets remains
one of the priorities of the modern medical and biological community.
Considerable attention is focused on study of the mechanisms of occurrence and
maintenance of the intra-tumor heterogeneity [4]. According to the concept of cancer
stem cells (CSCs), the growth and metastasis of the tumor are caused by the functioning
of a small population of tumor cells with specific properties. These cells should have a
number of functional characteristics, namely, a high ability to form tumors in the body
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of immunosuppressed mice when administered in limited quantities, the ability of selfmaintenance and proliferation, and increased resistance to cytostatics. There are some
similarities and differences between CSCs and healthy stem cells. The exclusive ability of
CSCs to self-renew and to form the heterogeneous lineages of cancer cells that comprise
the tumor bears resemblance to normal stem cells (NSCs). Targeting CSCs is an appealing
approach for treating cancer [5–7].
With the isolation and characterization of CSCs from different solid tumors, CSCs are
regarded now as a subset of the cells that have the ability of self-renewal and generation of
heterogeneous tumor cells. However, mechanisms underlying the CSCs self-renewal regulation remain mostly unknown [8]. While pluripotency in regulating genes of NSCs (such
as Oct4 and Nanog) was shown to regulate the CSCs self-renewal, noticeable differences exist between the NSCs and CSCs in their self-renewal regulation [9–11]. For colon cancer, the
most actively studied markers of the cancer stem cell are: CD133+ [12,13], CD44+ [14,15],
EpCAM [16], CD29, CD24 [17], CD166 [18], ALDH1A1+ [19], and ALDH1B1 [20]. The
simultaneous use of several markers for “stem cell-like” subpopulation enrichment allows
isolation of the stem subpopulation of tumor cells more reliably and accurately [21].
The methods of enrichment based on the separation of cells with a pronounced
manifestation of one of the CSCs’ functional properties are also described. An example
is the isolation of cells capable of actively ejecting Hoechst dye via ATP-dependent ABC
transporters, by fluorescence activated cell sorting (FACS), or antibodies conjugated to
magnetic beads (MACS) [22], or isolation of radioresistant cells [23]. The stem component
enrichment method based on the expression of aldehyde dehydrogenase (ALDH), for
example, using the ALDEFLUOR set [24], is also reported. Despite the simplicity of these
methods, not all obtained cells have a full set of CSC properties. For example, it is not
always possible for them to form tumors in immune-deficient mice [25]. It is assumed, in
particular, that proteolytic enzymes used in the process of cell isolation from tumor tissue
cause damage to a significant part of the surface receptors [26]. The most complex method,
but the one increasingly gaining popularity, is an enrichment based on the identification of
cells expressing embryonic transcription factors. As a rule, this is implemented through
the use of reporters containing parts of the promoter and enhancer regions of embryonic
transcription factor [27]. In our work, we used the SORE6x genetic construct developed by
the group of Binwu Tang [28]. This reporter contains six times repeated sequence of the
Nanog gene promoter which is a binding site for the OCT4 and SOX2 key transcription factor
of pluripotency. The use of a destabilized version of the GFP-dsCapGFP protein, which
has a short half-life in the cell, can increase the sensitivity of reporter cells. Previously, the
use of this reporter construct for enrichment of CSCs of various tumors was described. The
great advantage of the reporter constructs is the ability to indirectly monitor the promoter
activity in living cells in vitro or in vivo, during various functional experiments studying
the mechanisms of the CSCs’ formation and searching for the factors that stimulate their
formation [29]. There is growing evidence that the CSC state is dynamic and amenable to
rapid transitions [29,30]. In a number of papers, the appearance of the stem phenotype
in differentiated cells (phenotype change) in response to the various pathological and
physiological effects was noted [31]. A body of studies revealed the promoting effects of
the epithelial-mesenchymal transition (EMT) on the stemness of CSCs [32–35]. Similar to
the embryonic development, EMT plays a role in wound healing and development of some
diseases, such as fibrosis. In cancers, EMT is both associated with tumor metastasis, and
also with the acquisition of tumor cells with stem cell properties [36,37].
Clarification of the genetic, epigenetic, and external conditions that allow the implementation of broad phenotypic plasticity contributing to the activation of the mechanisms
of self-maintenance and protection of embryonic stem cells will significantly advance the
treatment of common forms of malignant tumors.
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2. Results
2.1. Enrichment of Cancer Stem-Like Cells from the Primary Culture of the Human Colon Cancer
The use of primary cell culture allowed us to reduce the influence of culture factors on
the biological characteristics of tumor cells. The selection of material for work, verification
of the histological diagnosis, and interpretations of the immunohistochemistry (IHC)
staining results were conducted by a certified pathologist. The histological structure
of
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW
4 of 31
the tumor serving as a source of the cells corresponded to a moderately differentiated
adenocarcinoma (Figure 1A,B, Supplementary Figure S1). Additionally, it was found that
more than 35% of the cells expressed the ALDH1A1 stem cell marker.

Figure 1. Obtaining a heterogeneous population of tumor stem cells. (A) Schematic representation of the experiment
design. The source of the primary BSC8 cell line was human colon adenocarcinoma. CSC-like cells were obtained by
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the degree of intraclonal heterogeneity of the cells, which could be judged by the level of
GFP fluorescence (Figure 1D). In order to select the most malignant clone, we determined
the degree of cell chemosensitivity to the effect of various concentrations of the most active
cytostatics widely used in clinical practice (5-FU, oxaliplatin, and SN-38). The results for
one of the clones compared to the original line are shown in the Figure2.
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the original paper, the authors also pointed out that the design allows “discarding” the
products of the pseudogenes of the Oct4 gene, which makes its use a highly effective method
for the CSC enrichment. Activation of the reporter leads to the puromycin resistance and
the expression of the destabilized form of GFP (with four-times shorter half-life than the
original GFP). The use of these properties allowed us to select subpopulation of puromycinresistant cells and analyze their CSCs-like properties comparing them with the cells of the
original BSC8 line. After viral transduction and selection on the medium with puromycin
during 5 days, more than 98% of cells died. The remaining puromycin-resistant cancer cells
were called BSC8_SORE+and used for the transcriptome analysis.
We assumed that the resulting subpopulation of cells has properties similar to stem
cells, based on the fact that the reporter structure assumed the acquisition of resistance
only by cells with endogenous expression of recognized stem factors OCT4 and SOX2.
It is known that cancer stem cells, according to their definition, are responsible for the
formation of tumors and maintaining their growth, and one of their properties is increased
resistance to cytostatics used in cancer therapy. Based on the property of increased resistance to 5-fluorouracil compared to the original cell line, we performed subcloning of the
resulting population of puromycin-resistant cells and compared the chemoresistance of the
obtained subclones.
2.2. The Increased Cytostatic Resistance of Cell Clones Selected after Reporter Transduction
We compared the functional properties of several cell clones obtained from a population of BSC8_SORE + cells. During the growth of the clones, we observed an increase in the
degree of intraclonal heterogeneity of the cells, which could be judged by the level of GFP
fluorescence (Figure 1D). In order to select the most malignant clone, we determined the
degree of cell chemosensitivity to the effect of various concentrations of the most active cytostatics widely used in clinical practice (5-FU, oxaliplatin, and SN-38). The results for one
of the clones compared to the original line are shown in the Figure 2. BSC8_SORE+/Clone
10 showed a seven-fold increase of the resistance to 5-fluorouracil (5-FU) treatment, fivefold to SN-38, and six-fold to oxaliplatin (Figure 2). The doubling time of the BSC8 line
cells is 17 h, whereas in enriched stem cells (Clone 10) it is 23.3 h (1.3 times higher). Given
that the chemoresistance is considered as one of the major properties of CSCs, further work
done to characterize this clone.
2.3. Clone Formation under Normoxia and Hypoxia and Cell Migratory Activity Analysis
Next, we analyzed the expression of stem cell markers in the obtained cell line with the
endogenic OCT4 and SOX2 expression. The levels of expression and the patterns of marker
localization in the tumor cells of the original BSC8 cell line were similar to those of the
BSC8_SORE+ line. There was no difference in the proportion of the cells expressing CD44,
and its cytoplasmic expression as determined by staining was found in at least 40 percent
of the cells. A significant increase in the proportion of LGR5 positive cells was noted in
the BSC8_SORE+ cells. Weak cytoplasmic staining was found, when the antibodies to the
OCT4 key embryonic stem cell transcription factor were used (Supplementary Figure S2).
We analyzed the functional characteristics of the isolated cell clones, such as clonogenic
and migratory activity, as well as the mobility and chemoresistance. This analysis revealed
that the cells do not differ in the level of clonogenic activity in a semi-liquid agar. Cells
formed the same number of colonies, which also were identical in shape and size. The
role of cultivation under hypoxic conditions was also analyzed. A larger number of cells
expressing GFP on a section of colonosphere formed under hypoxic conditions can be noted.
A looser structure of the colony in hypoxia was also noted (Supplementary Figure S3).
When growing BSC8_SORE+/Clone 10 cells on plastic, we observed an increase in the
intraclonal cell heterogeneity. The levels of dsGFP expression visibly changed. During the
flow cytometry analysis, we found the presence of 2 cell populations with 100× differences
in the degree of fluorescence. The number of brightly fluorescent cells was twice as low as
the number of cells with low level of GFP expression (Figure 1D).
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Figure 2. Inhibitory effect of 5-FU, SN-38, and oxaliplatin on cell growth. Cells were treated with
Figure 2. Inhibitory effect of 5-FU, SN-38, and oxaliplatin on cell growth. Cells were treated with
increasing concentrations of 5-FU, SN-38, or oxaliplatin for 48 h, and cell viability was determined by
increasing concentrations of 5-FU, SN-38, or oxaliplatin for 48 h, and cell viability was determined
the MTT assay. Each point represents the means ± SD. Experiments were performed in biological
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the endogenic OCT4 and SOX2 expression. The levels of expression and the patterns of
BSC8_SORE+/Clone 10/GFP + cells exhibited increased clonogenic activity when culmarker localization in the tumor cells of the original BSC8 cell line were similar to those
tured on plastic (Figure 3A). A ten-fold increase in the clonogenic activity of GFP+ cells
obtained from BSC8_SORE+/Clone 10 cells was observed compared to the control samples
(Figure 3B). We did not find differences in the clonogenic activity of “non-green” cells

on plastic (Figure 3A). A ten-fold increase in the clonogenic activity of GFP+ cells obtained
from BSC8_SORE+/Clone 10 cells was observed compared to the control samples (Figure
3B). We did not find differences in the clonogenic activity of “non-green” cells (GFP-) obtained from the BSC8_SORE+/Clone 10. In this case, the clonogenic activity was the same
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Figure 3. Clonogenic activity of the BSC8 tumor cells. (A). Formation of the cell colonies by the BSC8_SORE+/Clone
Figure 3. Clonogenic activity of the BSC8 tumor cells. (А). Formation of the cell colonies by the
10/GFP+, BSC8_SORE+/Clone 10/GFP- cells and the original BSC8 cell line on plastic. An increase in the size of the colonies
BSC8_SORE+/Clone 10/GFP+, BSC8_SORE+/Clone 10/GFP- cells and the original BSC8 cell line on
formed underplastic.
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is size
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(B). Diagram
of the
number
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under
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(B).and GFPcells on plastic. A ten-fold increase in the clonogenic activity of the GFP+ cells is observed. All results are representative of
three independent experiments. * p ≤ 0.05. Bars = standard deviation.

When cells were cultured under hypoxic conditions, there was a slight increase in
the number of colonies, both in the original cells and in the SORE+ “stem-like” cells. We
should also emphasize the increase in the size of the growing colonies, where the hypoxic
conditions resulted in larger colonies (Supplementary Figure S3).
Next, we analyzed the cell migratory activity by measuring the “wound repair” rate
and by monitoring migration through the membrane of the Boyden chamber towards
chemoattractant (represented by the medium with FBS). It was found that in comparison
with and the original BSC8 line, the BSC8_SORE+ cell line was characterized by the
somewhat reduced level of mobility—it took these cells more than five days for complete
wound closure (Figure 4A,B). When analyzing migration activity through the pore towards
the nutrient, the BSC8_SORE+ cells showed more than two times higher migration rate
than the cell mobility of the original cell line. The large size of the formed colonies
indirectly indicates a high clonogenic activity of the cells migrating through the membrane
(Figure 4C,D).
2.4. Tumorogenic Activity of 5-FU Resistant Cells Compared to the Original Cells in the
Xenograft Assay
CSCs are characterized primarily by their ability to regenerate new tumors in vivo.
And although we observed properties similar to those of cancer stem cells, including
increased cell chemoresistance, only an analysis of cell ability to form a tumor when injected
into nude mice compared to the cells of the original cells could allow us to count them as
CSCs-like cells. The results of the immunohistochemical staining of the original tumor and
formed after BSC8 cells injection under the skin of an immunodeficient mouse withantibody
CK-20; beta-catenin; CDX2; ALDH (data not shown) were similar, the intestinal origin of
the tumor regeneraated in the mouse is not in doubt (Figure 5, Supplementary Figure S4).
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Figure 4. Comparison of the migratory activity of the “stem-like” BSC8_SORE+ cells and original
BSC8 cells. (A). The growth of the SORE+ and original BSC8 cells during the “wound repair” test
(original magnification 4×). (B). The intensity of wound healing by the SORE+ and original BSC8
cells. Complete closure (overgrowing) of the cell-free surface occurred on average after five days.
A slight decrease in the migratory activity of the BSC8_SORE+ cells is observed. (C). Representative
images from a Boyden chamber motility assay (original magnification 20×). (D). Quantitative
analysis reflected the accelerated migration of the BSC8_SORE+ cells comparing with original BSC8
cells (437 ± 66.5 and 874 ± 25.5 clones per well, respectively; * p < 0.001). The results are averages
with standard errors (n = 3 for each group).

In our xenograft model experiments, the cells were injected into the immune-deficient
nude mice subcutaneously in the thigh area, a single-cell suspension of 500,000 cells in
100 µL of Hanks’ solution. In the experiment, 10 nude mice were taken (one died), the
size of the tumors measured on day 40 after the injection of BSC8_SORE+ cells (left thigh)
and BSC8 (right thigh) is shown in the Figure 5 and Supplementary Figure S4. Due to the
limited number of Nude mice injections were given under both legs. Thus, we compared
the ability of injected cells to regenerate new tumor and the sizes of them. Tumorogenic
activity was evaluated by measuring the tumor diameters at the time of 20, 30 and 40 days

Int. J. Mol. Sci. 2021, 22, 4682

8 of 29

from the day of injection. Thus, it is shown that the enrichment of the BSC8population
with the help of a reporter containing a promoter of the nanogene carrying a binding site
for the Oct4/Sox2 complex, contributes to an increase in their tumorogenicity. We believe
that our results show the activity of expression of POU-domain transcription factors in
the stem-like component of the tumor population and characterize this family of proteins
as a marker of cancer stem cells and a potential target for genetic cancer therapy. The
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW
9 of they
31
characteristics of the BSC8_SORE+ cells we present give us reason to believe that
are similar to cancer stem cells, and further in the text we allow ourselves to call them a
subpopulation of CSC-like cells.

Figure 5. Comparison of the tumorogenic activity of the “stem-like” BSC8_SORE+ cells and original
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2.5. The Transcriptomic Landscape of the SORE+ Cells

2.5. TheBSC8_SORE+
Transcriptomiccancer
Landscape
the SORE+
stemofcell-like
cellCells
line demonstrated differential expression of
12831
genes
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BSC8
control
line.
Ofdemonstrated
these genes, 5973
were up-regulated
and
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were
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6)
12831 genes compared to BSC8 control line. Of these genes, 5973 were up-regulated and
To identify
the most(Figure
prominent
6451 were
down-regulated
6) functional effects, we first constructed the proteinprotein interaction network (PIN) for proteins encoded by the most up- or down-regulated
genes with the expression difference of more than 10-fold and with the best interaction
confidence (>0.9). The network was constructed using the String server (https://string-db.
org/, accessed on 12 August 2020). Next, we extracted the whole connected component
from the induced and inhibited networks and performed k-means clustering using the
same server. Figure 7 and Supplementary Figure S5 show versions with short and extended
legends of the induced and the inhibited PINs. It is clearly seen that the up-regulated and
down-regulated networks contain the large tightly linked clusters involved simultaneously
in several functions that confirm a modular pattern of transcriptome changes. The pattern
of gene function distribution among various clusters indicated that in accordance with the
experimental data, BSC8_SORE+ demonstrated clear manifestations of drug resistance,
pluripotency, and decreased proliferation rate. Below, we provide a detailed description of
the main clusters from the up- and down-regulated PINs. The regulators containing more
than five bonds, we designated as hub proteins.
Figure 6. Volcano plot for differential gene expression. BSC8_SORE+ vs BSC8 cells as control. X axis
–Log2 fold change for BSC8_SORE+ vs BSC8 cells. Y axis –log10 of adjusted p-value for fold change.
Green dots are significantly up-regulated genes, red dots are significantly down-regulated genes.
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from the induced and inhibited networks and performed k-means clustering using the
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phototransduction signaling that mediate neuronal morphogenesis [40]. The PIN for the
down-regulated genes contained 12 clusters. The induced PIN also revealed the features of
drug resistance. It can be seen from the cluster of drug metabolism through cytochrome
p450 pathway (hubbed by IDO1), leptin signaling, and Toll-like receptors. The induction of
these clusters both confirmed our experimental results indicating a higher drug resistance
(specifically, for 5-fluorouracil), and also showed which particular pathways confer this
property [41,42].
The PIN for the down-regulated genes is shown in Figure 7B and Supplementary
Figure S5B. The expression fold difference for the down-regulated genes from this PIN
is shown in Supplementary Table S2. The PIN for the down-regulated genes contained
11 clusters and also showed manifestations of stemness. For example, the clusters of
aging (the main hubs are AKT (PPIDRPONDR-FIT = 18.3%), mTOR (23.6%), and EDN1
(44.3%) and differentiation (the main hub is MAPK9 (PPIDRPONDR-FI T = 18.4%) point
to dedifferentiation (Figure 7B, Supplementary Figure S5B). The clusters of cell cycle
regulation evidence of slow cell cycling. This feature is a well-known manifestation of
stemness [43] Many hubs of these clusters were classical cell cycle regulators of E2F, cycline
(CCN), and CDK, RB, and PCNA families. Another important cell cycle-related cluster
was implicated in chromatin modification via histones (cluster 1, the main hubs were
HIST1H2 (PPIDRPONDR-FIT = 78.4%) and HIST3H2 (PPIDRPONDR-FIT = 44.4%). The clusters
of immune response and inflammation via interferon signaling, chemokines and TNF
(PPIDRPONDR-FIT = 12.4%) in the PIN of down-regulated genes suggest a decreased activity
of pro-inflammatory signaling. Since pro-inflammatory signaling stimulates stem cell
differentiation [44], the decrease of the activity of this pathway also points to the cell
dedifferentiation.
Therefore, the functional picture provided by PIN clusters for the inhibited and
induced genes indicated that compared to the BSC8 control cells, BSC8_SORE+ cells
demonstrate manifestations of the pluripotency and drug resistance. The unexpected result
was the induction of genes participating in the leptin signaling and phototransduction.
BSC8_SORE+ cells also showed the coordinated down-regulation of signaling involved
in the cell cycle regulation, and phase transition, inflammation, aging, and differentiation,
which complements the data obtained with the induced network.
2.7. Gene Module Analysis
To obtain a transcriptome-wide picture and to find out whether the discovered effects
were manifested globally, we performed Gene Ontology (GO) and Cancer BioSystems
analysis of functional gene modules (by averaging gene expression). Sixty most significantly up- and down-regulated modules are shown in Figure 8A–D and Supplementary
Tables S3–S6. The results of this analysis provided important support to the PIN analysis
data. For example, similar to the trends found by the analysis of PIN clusters, the substantial number of the induced modules from both databases were related to the pluripotency,
including signaling via NODAL (PPIDRPONDR-FIT = 13.3%) and activin (branches of the
TGF-β pathway), and signaling via Yamanaka factors (POU5F1 (PPIDRPONDR-FIT = 39.4%),
NANOG (62.8%), and SOX2 (95.3%). Additionally, several modules were related to TGF-β,
c-Kit, and FGF signaling and to EMT and stemness, as well as to male gametogenesis
and development (Figure 8A,C, Supplementary Tables S3 and S5). A large number of the
up-regulated modules were also involved in the response to various stressors and stimuli,
such as drug resistance and antimicrobial immunity. Importantly, gene module analysis
confirmed the activation of phototransduction and leptin signaling pathways. The new
features revealed by the gene module analysis were the up-regulation of cancer-related
modules including calcium and HIF1α signaling, pathways of glycolysis, cancer, and
negative regulation of apoptosis (Figure 8B,C).
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In accordance with the PIN analysis results, the down-regulated gene modules were
related to the cell growth, proliferation, cell cycle regulation and phase transition, aging, differentiation, chromosome organization, chromatin remodeling, immune response
(including interferon signaling, inflammation, antigen processing, and cytokine signaling), and RNA metabolism (Figure 8B,D, Supplementary Tables S4 and S6). The new
down-regulated modules were represented by several pathways related to apoptosis and
numerous pathways associated with the protein metabolism. Therefore, the gene module
analysis results confirmed that the effects identified for the most deregulated genes by PIN
analysis apply to the entire transcriptome.
To verify the resistance of the BSC8_SORE+ cells to 5-fluorouracil via the in silico
analysis, we used CDRgator (Cancer Drug Resistance navigator) [45]. CDRgator (http:
//cdrgator.ewha.ac.kr, accessed on 15 September 2020) is a database that unifies data on
the drug resistance gene signatures for about 1000 cancer cell lines and cancer cells of
resistant patients (for about 30 drugs). Of all gene signatures, we selected ones involved
in the regulation and responsible for the 5-fluorouracil resistance of colorectal carcinoma.
As a result, we obtained three gene signatures (30, 35, and 600 genes) and compared them
with our gene expression data using binomial test for the statistical significance evaluation
(Supplementary Table S7).
2.8. Intrinsic Disorder Predisposition of Proteins Encoded by Genes Differently Expressed in the
BSC8_SORE+ Cells vs. BSC8 Control Cells
High binding promiscuity and capability to interact with various often unrelated
partners serve as characteristic features of intrinsically disordered proteins (IDPs) or hybrid
proteins containing ordered domains and intrinsically disordered protein regions (IDPRs) [46–52]. IDPs/IDPRs are capable of forming static, semi-static, dynamic, or fuzzy complexes [46–48,50–52], be engaged in semi-static and dynamic polyvalent interactions [53,54],
bind partners with high specificity and low affinity [55], and fold (at least partially and
often differently) at interaction with different specific partners [56–62]. High structural
and functional heterogeneity of IDPs/IDPRs and their complexes [50,52] defines protein structure-function continuum, where a dynamic conformational ensemble of a given
protein includes multiple conformational, inducible, and functioning proteoforms (i.e.,
different molecular forms in which the protein product of a single gene can be found) characterized by a broad spectrum of structural features and possessing various functions [63].
Since IDPs/IDPRs are known to play crucial roles in PIN regulation, and since many
IDPs/IDPRs serve as hub proteins [61,64–68], we also evaluated intrinsic disorder predispositions of the proteins encoded by the up- and down-regulated genes with very high
significance in the CSC-like BSC8_SORE+ cell line (Supplementary Tables S8 and S9). The
genes encoding these proteins are also listed in Supplementary Tables S1 and S2.
Figure 9A represents results of the CH-CDF analysis of these two protein sets. This
approach allows predictive classification of proteins based on their position within the
CH-CDF phase space into structurally different classes, such as ordered proteins, proteins
with compact disorder/hybrid proteins and proteins with extended disorder [69–72]. This
analysis revealed that among the 219 induced proteins, 21 proteins is expected to be highly
disordered, 32 proteins might have a molten globular or hybrid structure, and 164 proteins
are mostly ordered. Curiously, 175 inhibited proteins showed a bit different disorder status,
with 15, 51, and 107 being expected to behave as native coils/native pre-molten globules,
native molten globules/hybrid proteins, and ordered proteins, respectively. In other words,
24.2% of the induced proteins and 37.8% of the inhibited proteins are expected to have high
levels of intrinsic disorder.
Based on the peculiarities of the results generated by the per-residue disorder predictors, such as content of disordered residues (or percent of predicted intrinsically disordered
residues, PPIDR) and mean disorder score (MDS), proteins are typically grouped into three
categories: highly ordered (PPIDR = 0–10% or MDS = 0.00–0.25), moderately disordered
(PPIDR = 10–30% or MDS = 0.25–0.50), and highly disordered (PPIDR greater than 30%
or MDS greater than 0.50). Obviously, the MDS value calculated for a given protein is not
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Overall, this PONDR® FIT-based analysis indicated that the majority of the induced
and inhibited proteins are either moderately or highly disordered. In fact, in the induced
set, 68 (31.1%), 96 (43.8%), and 55 proteins (25.1%) have PPIDR scores of PPIDR < 10%,
10% ≤ PPIDR < 30%, and PPIDR ≥ 30%, respectively, indicating that 68.9% of these proteins are either highly or moderately disordered. Similar picture is observed, when these
proteins are grouped based on their MDS values: 95 (43.4%), 94 (42.9%), and 30 (13.7%)
have MDS < 0.25, 0.25 ≤ MDS < 0.5, and MDS ≥ 0.5, respectively. Therefore, based on
their MDS values, high or moderate levels of disorder is found in 124 (56.6%) induced
proteins. Application of the analogous classification to inhibited proteins indicated that
39 (22.3%), 71, (40.6%), and 65 (37.1%) of them have PPIDR < 10%, 10% ≤ PPIDR < 30%, and
PPIDR ≥ 30%; and 52 (29.7%), 92 (52.6%), and 31 (17.7%) of these proteins have MDS < 0.25,
0.25 ≤ MDS < 0.5, and MDS ≥ 0.5. In other words, based on their PPIDR/MDS values,
77.7%/70.3% of inhibited proteins belong to moderately or highly disordered category.
Figure 9B also gives us a possibility to select the most disordered proteins in the sets,
as proteins possessing MDS ≥ 0.5 and/or PPDR ≥ 30%. This analysis indicated that
55 (25.1%) and 65 (37.1%) of the induced and inhibited proteins satisfy these criteria. Even
using PPIDR ≥ 50% as the most stringent criteria for the protein to be classified as highly
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disordered, we found that 26 (11.9%) and 29 (16.6%) of the induced and inhibited proteins
belong to this category.
Curiously, although it seems that the inhibited proteins are a bit more disordered
than the induced, ones, the Top-10 induced proteins showed higher levels of disorder and
the Top-10 inhibited proteins. In fact, PPIDR scores of 10 most disordered proteins in the
induced set ranged from 97.6% to 76%, whereas in the inhibited set, 10 most disordered
proteins were characterized by the PPIDR scores were somewhat lower ranging from 90.8%
to 67.1%. Finally, the potential relation of intrinsic disorder to the functionality of induced
and inhibited proteins was stressed out by adding the corresponding PPIDR values to the
proteins discussed in the previous sections and in Discussion section below. Importantly,
most of these proteins are either moderately or highly disordered, indicating that the
intrinsic disorder is needed for the function of proteins associated with stemness of CSCs.
3. Discussion
In this study, we obtained a line of the colon adenocarcinoma stem-like cells. The
selection was based on the activation of reporter genes driven by the binding of the SOX2
and OCT4 endogenous stem cell factors. Selected cells were characterized by increased
clonogenic and migration activity, and also showed increased resistance to cytostatic drugs.
Using bioinformatics methods, we analyzed the levels of gene expression, combining
them into functional groups, followed by the analysis of their roles in the maintenance
and functioning of tumor stem cells. We also checked the intrinsic disorder status of the
corresponding proteins.
Stem cell renewal can be achieved by symmetric division, as well as asymmetric
division [73,74]. Symmetric division of stem cells is a highly conservative and precisely
regulated process of division resulting in formation of two cells, which differ in potentials,
morphology, and functions [75]. During long-term cultivation, the population of GFP+
cells acquire heterogeneity, which we explain by the differentiation of the part of the cells.
FACS sorting of this heterogeneous population allowed us to obtain cells with low and high
clonogenic activity. The clonogenic activity of the BSC8_SORE/Clone 10/GFP+ cells were
10 times higher than the activity of the cells from the original BSC8 line. This confirmed
that the GFP+ cells had stem properties.
It is assumed that only cells with unlimited proliferation ability are capable of forming
clones both in vitro and in vivo in immunodeficient mice [76,77]. An increase in the
clonogenicity of tumor cells under the influence of various factors (for example, activation
of the expression of embryonic transcription factors) is interpreted as an increase in the
“stemness” and, hence, malignancy potential [76]. The transcriptome analysis revealed
high levels of expression of a number of stem factors involved in the ensuring both normal
and tumor stemness. Next, we described some of these factors in more detail.
Due to the growing interest in tumor stemness, a lot of results have been accumulated concerning the expression of OCT4 variants in tumors of different localization, and
although OCT4A expression is limited to embryonic cells and embryonic carcinoma cells,
it has been noted that OCT4B is expressed in human somatic stem cells, tumor cells, adult
tissues, and pluripotent cells [78–82]. The pluripotency is an important feature of the CSCs
that promotes the self-renewal and chemoresistance. Preservation of embryonic stem cell
(ESC) pluripotency under the different pathophysiological conditions requires a complex
interaction between different cellular pathways, including those involved in the homeostasis and energy metabolism. However, the exact mechanisms that support CSC pluripotency
remain unclear. It seems that the molecular pathway of the self-renewal in normal stem
cells is the same as that of CSCs in tumor [83]. Many self-renewal regulatory factors, such
as OCT4, SOX2, BMI, and NANOG, are expressed in human malignant tumors, and they
play an important role in carcinogenesis.
The ability of CSCs to self-maintain, being a common feature with ESCs, provides CSCs
with the ability to form metastatic tumors and also contributes to the activation of some
embryonic mechanisms to protect cells from the effects of chemotherapy and autoimmune
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aggression. The expression of many oncofetal and testicular antigens generally correlates
with a negative clinical prognosis of cancer. We will discuss only some examples of proteins
characteristic for CSCs, which were identified during comparative analysis of BSC8_SORE+
and the original BSC8 cell line transcriptomes.
Among the genes with an increased level of expression in the BSC8_SORE+ cells, we
should note a few key factors of ESC maintenance and some factors involved in the chromatin remodeling, such as: SOX2 (PPIDRPONDR-FIT =95.3%), SOX11 (77.6%), SALL4 (43.6%),
PRDM14 (23.8%), L1TD1 (55.4%), LIN28B (47.4%), POU5F1 (39.4%), DPPA2 (36.9%), and
NANOG (62.8%). The high level of expression of these factors in tumors always indicates a
high aggressiveness of the process and serves as negative prognostic factors. Increased activity of core embryonic transcription factors—OCT4/POU5F1 (PPIDRPONDR-FIT = 39.4%),
SOX2 (95.3%), and NANOG (62.8%)—in the BSC8_SORE+ cells is probably involved in
implementing the CSC self-maintenance and pluripotency properties in the same way as
described for embryonic stem cells.
As an example of a protein with an increased level of expression, we should mention
another important transcription factor encoded by the oncofetal gene, SALL4
(PPIDRPONDR-FIT = 43.6%) [84,85]. Along with other solid tumors, its increased expression is described in colon cancer cells [83]. An increased expression of co-receptor for
nodal signaling pathways TDGF-1/CRIPTO-1 (PPIDRPONDR-FIT = 10.6%) is observed in
the BSC8_SORE+ cells, also previously described as a factor of unfavorable prognosis. This
factor plays an important role in the maintenance of stem cells and in the activation of
cell metastatic abilities by increasing mobility, increased MMP2 (PPIDRPONDR-FIT = 2.42%)
expression, induction of EMT transition and chemokine receptor CXCR4 [86–90].
The results of numerous studies confirm the role of a complex of pathways involved
in the cell chemoresistance in the biology of CSCs and the realization of their stem potential.
According to the transcriptome analysis, the BSC8_SORE+ cells express the elevated levels
of ABCB5 (PPIDRPONDR-FIT = 8.04%). Its expression allows tumor cells to form a multidrug
resistance (MDR) phenotype enabling the resistance to 5-FU chemotherapy [91,92]. A
number of studies have shown the role of ABCB5 in the implementation of resistance and
functioning of cancer stem cells of such types of such solid tumors as that of the oral cavity
and colon cancer [93,94]. The CYP1A2 (PPIDRPONDR-FIT = 5.43%) involved in the phase
1 excretion of xenobiotics, is expressed at elevated level in the BSC8_SORE+ cells. IDO1
(Indoleamine 2,3-dioxygenase) is a key regulator of the activity of these enzymes. IDO1
metabolites (in particular tryptophan metabolites) are capable of inhibiting the functions of
cytotoxic T lymphocytes, leading to local immunosuppression [95–98].
The activity of co-transporters and enzymes can significantly reduce the intracellular
concentration of drugs. The combination of the activity of DNA repair systems together
with the violation of the restriction points of the cell cycle leads to the CSC survival
accompanied by a gradual accumulation of new mutations. As for DNA repair, it should
be noted that the increased activity of a number of auxiliary proteins, such as NEK8
(PPIDRPONDR-FIT = 12.4%), taking part in the activity of RAD51-dependent DNA repair
(NEK8 regulations of DNA damage-induced RAD51 foci formation and replication for
protection) were also shown in the BSC_SORE+ cells.
An important role in ensuring cytostatic resistance is the retention of cells in a state
of mitotic rest (G0 phase). “Dormant” tumor cells are not sensitive to most cytostatic
agents, as well as are more resistant to adverse microenvironment conditions of distant
metastasis formation [99]. One of the distinctive features of the BSC8_SORE+ cells is
the cell cycle slowing down and the cell metabolism inhibition. According to experimental data, the BSC8_SORE+ cell cycle duration is 23.3 h, which is 1.3 times longer
than original BSC8 cells have. Two gene clusters are implicated in the cell cycle regulation. Hubs (E2F4-8 (PPIDRPONDR-FIT = 50.6%, 39.9%, 24.9%, 45.2%, and 34.5%, respectively), CCNE (26.6%), POLE (7.02%), PCNA (15.7%), and RB1 (28.0%), and other hubs
(CCNA (PPIDRPONDR-FIT = 7.96%), CCNB1 (36.0%), CDKN1B (76.8%), CENPP (17.0%),
CDK8 (28.7%), and FOXM1 (61.6%) are reflected in the lower level of mitotic activity. At the
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same time, we can observe the inhibition of protein metabolic activity. Signs of metabolic
deprivation are also consistent with the cell cycle slowing down. It is known that the
cell cycle slowing down is one of the key CSC properties and can lead to an increased
resistance to cyclo-dependent cytostatics (5-FU and SN-38) [100]. The selection of a cell
population with a low cycling rate is one of the methods of enrichment of highly malignant
cells. The selected cells correspond to the CSC criteria and exhibit the increased chemoresistance, clonogenic activity, migratory activity, and also express various extracellular
matrix-degrading enzymes [75,101,102].
One of the most important aspects of the tumor cell functioning is the mechanisms of
local immunosuppression. The inhibition of the cluster of proteins involved in interferon
signaling (such as IFIT2 (PPIDRPONDR-FIT = 22.7%), IFIT44 (3.60%), TRIM14 (18.8%), etc.),
the TNF-signaling (such as TNF (PPIDRPONDR-FIT = 12.4%), RIPK1 (27.6%), MAP3K1
(47.9%), IFIH1 (22.1%), TRAF3 (18.7%), etc.) were observed in the BSC8_SORE+ cells.
There is an increased IL-10 (PPIDRPONDR-FIT = 18.5%) expression level that can lead to a
variety of immunological reactions including suppression of cytokine synthesis, antigen
presentation, and suppression of CD4+ T lymphocytes. STAT3 (PPIDRPONDR-FIT = 15.3%)
expression activation observed according to the transcriptome analysis (noted previously)
can be caused by the IL-10 expression.
The expression levels of chemokine receptors and their ligands, such as CXCR2,
CXCL14, CCL16, CXCL17, CCL28, and CCL22 (with the PPIDRPONDR-FIT of 13.1%, 32.3%,
24.2%, 72.3%, 35.4%, and 18.3%, respectively) were also increased in BSC8_SORE+ cells.
At the same time, there was the repression of CXCL1, CXCL3, CXCL8, CXCL10, and
CXCL11 (PPIDRPONDR-FIT of 24.5%, 25.2%, 16.2%, 24.5%, and 23.4%, respectively). In
physiological conditions, chemokines participate in the directed movement of immune
cells (in particular lymphocytes). Their role in the development of tumor cell metastasis to
lymph nodes and distant organs is assumed to be guiding [103,104]. There are also papers
showing chemokines participation in the stem cell functioning processes. Overexpression
of CCL28 enhances cell proliferation, as well as their migration and clonogenic properties [105]. According to the authors, these manifestations occur due to the MAP kinase
cascade activation.
The aforementioned CXCR2 overexpression is consistent with the literature data
stating that the CXCR2 overexpression on the surface of tumor cells is a marker of poor
prognosis for some types of cancer [106–109]. The use of CXCR1/2 oral inhibitors leads to
the inhibition of metastasis to the liver of colon cancer due to the inhibition of neovascularization and increased apoptosis of tumor cells [110]. The importance of angiogenesis for
tumor growth and spreading is undeniable. In the obtained stem cells, we observed the
increased expression of angiopoietins ANGPT2 and ANGPT4 with the PPIDRPONDR-FIT
of 8.07% and 32.8%, respectively, which are the TIE2 receptor ligands on the surface of
endothelial cells [111,112]. Their expression promotes VEGF-independent tumor neovascularization. According to the literature, they are negative prognostic markers [113–117].
Finally, our bioinformatics analysis indicated that a significant portion of up- and
down-regulated proteins in the CSC-like BSC8_SORE+ cells are moderately or highly disordered. In fact, induced and inhibited proteins contain variable levels of intrinsic disorder,
and their PPIDRPONDR-FIT values ranges from 2.21% to 97.6% and from 2.65% to 90.8%,
respectively. Consideration of the presence of intrinsic disorder in proteins associated
with the stemness of CSCs provides an important angle for better understanding of their
functionality. In fact, high disorder content in many stemness-associated proteins can be
related to the presence multiple posttranslational modification (PTM) sites and numerous
isoforms generated in these proteins by alternative splicing, as well as it can define their
binding promiscuity and ability to undergo binding induced folding at interaction with
specific partners. Such disorder-based structural and functional heterogeneity of human
proteins associated with CSC stemness is in agreement with the well-established fact that
IDPs or hybrid proteins containing ordered domains and IDPRs are typically involved
in recognition, regulation, and cell signaling [58,61,118–132], and are commonly found
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among proteins related to the pathogenesis of various human diseases [123,133–141]. These
findings are also in line with the previously reported roles of intrinsic disorder in reprogramming transcription factors (also known as Yamanaka factors, such as SOX2, OCT3/4
(POU5F1), KLF4, and c-MYC, and the Thomson factors, such as SOX2, OCT3, LIN28, and
NANOG), overexpression of which leads to the transformation of terminally-differentiated
somatic cells into the induced pluripotent stem (iPS) cells [142].
4. Materials and Methods
4.1. Obtaining the Primary Cell Line
The material for this study was obtained on the basis of the patients’ informed consent.
The ongoing research received the ethical approval of the ethics committee of the St.
Petersburg Clinical Research and Practical Center of Specialized Types of Medical Care
(Oncologic). Tumor material was obtained during the planned surgical treatment of
12 patients. Tissue fragments were transported to the laboratory within 6–12 h after surgery
in saline solution.
The cells were isolated from the primary tissue based on the recommendations of Yu
et al. [143] and according to our previous study [144]. Each sample was cut into pieces of
approximately one cubic millimeter in size and incubated in 10-fold (by volume) excess of
trypsin (Gibco, Gaithersburg, MD, USA) overnight in a refrigerator at 4 ◦ C, followed by an
hour incubation at 37 ◦ C. The action of trypsin was inhibited by RPMI medium with 10%
FBS (fetal bovine serum). This suspension of disintegrated cells was centrifuged to collect
the cells (150 g for 5 min). The cells were then resuspended in Roswell Park Memorial
Institute (RPMI) 1640 culture medium with 10% FBS and then plated on a 10 cm dishes.
The remaining “undigested tissue” was treated with a solution of collagenase in RPMI
medium with serum containing 500 units/mL of the enzyme, incubated in a Petri dish at
37 ◦ C for one hour. The released cells were collected, and cells were placed in a medium for
culturing in the incubator. The colorectal cancer cells were cultured in Dulbecco’s Modified
Eagle Medium (DMEM) medium (Gibco, Gaithersburg, MD, USA) with 10% FBS (Sigma,
Co, St.Louis, MO, USA). Cells were passaged using trypsin solution (Gibco, Gaithersburg,
MD, USA), once in three days at a ratio of 1:3. We used PCR-based testing with universal
primers specific to the 16S rRNA region for detecting mycoplasma contaminants in cell
culture [145–147]. Dulbecco’s Modified Eagle Medium (DMEM), Roswell Park Memorial
Institute (RPMI) medium, trypsin, DMSO, puromycin and fetal bovine serum (FBS) were
purchased from Sigma-Aldrich Co. (St.Louis, MO, USA).
4.2. Packaging of VIral Particles, Infecting Cells in Vitro, and Selecting Clones with Integrated
SORE6x Reporter
We used the HEK 293T human embryonic kidney cell line to obtain viruses. Cells
were transfected by the calcium phosphate method to introduce the SORE6x plasmid
reporter construct (courtesy of Dr. Tang) based on the lentiviral integrating vector, as well
as auxiliary plasmids to provide viral particle according to the standard protocol (https://
www.epfl.ch/labs/tronolab/wp-content/uploads/2019/06/LV_production.pdf, (accessed
on 19 July 2020) and our previous study [28]. Usually, infection was done twice (that
is, after a day, another 10 µL of viral particles were added). Three days after the virus
infection, the cells were transplanted to 10-cm culture cups (Corning Life Sciences, MA,
USA) in the culture medium. The next day, the puromycin antibiotic (Sigma-Aldrich Co,
St.Louis, MO, USA) was added to the medium at a concentration of 5 µg/mL. The selection
followed, changing the medium with the antibiotic every two days, for 10–14 days. We
selected growing colonies individually and, after treatment with trypsin, plated the cells
on a six-well plate.
4.3. Immunofluorescence Staining of Formalin-Fixed Paraffin-Embedded Tissue Sections
We hydrated the sections gradually with graded alcohols: washed in 100% ethanol
twice for 15 min each time, then in 90% ethanol twice for 15 min each time, and rinsed
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in deionized H2 O for 1 min. Antigen unmasking was provided by heat treatment with
10 mM sodium citrate buffer, pH 6.0 at 95 ◦ C for 5 min. Samples were incubated for
30 min with a blocking solution (1% horse serum in phosphate-buffered saline (PBS) and
washed with three changes of PBS for 5 min each). For staining, sections were incubated
with primary antibody diluted in PBS with 1% bovine serum albumin (BSA) for 60 min at
room temperature or overnight at 4 ◦ C followed by washing with three changes of PBS for
5 min each. Secondary antibodies were diluted in PBS with 1% BSA, and samples were
incubated at room temperature for 60 min in a dark chamber. Immediately after washing
with three changes of PBS for 5 min each, sections were covered with either an aqueous or
a hard-set mounting medium. They were examined using a fluorescence microscope with
appropriate filters.
4.4. Determining the Resistance to Cytostatics by the MTT Method
We evaluated the cell viability using a colorimetric method with MTT (Sigma-Aldrich
Co., St. Louis, MO, USA). The method is based on the fact that mitochondrial oxidoreductases of the living cells restore yellow MTT to purple formazan. The amount of formazan
produced correlates with the number of viable cells in the population. To determine the
sensitivity of colon adenocarcinoma cells to cytostatic drugs (5-Fluorouracil, SN-38, Oxaliplatin), we seeded 50,000 cells per well of a 96-well plate in a volume of 100 µL and added
25 µL of the drug solution with a five-fold relative final concentration. The drugs were
used at a concentration that allowed to determine the change in the cell line chemosensitivity (5-FU-100 ng/mL), or at a concentration for determining IC50. Cytostatic solutions
were prepared in several test concentrations. For each cell line studied, we seeded the
cells on six control wells–without adding the cytostatic. After incubation for two days in
a cell incubator, 10 µL of the MTT solution (5 mg/mL in PBS buffer) was added to the
medium followed by the incubation for 2–4 h. Then the medium was carefully removed
and formazan crystals were dissolved in 100 µL of DMSO (Sigma-Aldrich Co, St.Louis,
MO, USA). We measured the optical density at a wavelength of 570 nm on the Thermo
Electron Multiskan EX (Invitrogen, Thermo Fisher Scientific; Waltham, MA, USA). For each
experimental point, we repeated the measurement six times and calculated the standard
average error. The results were presented as the percentage of cells that survived cytostatic
treatment relative to the control (the number of cells that were not treated).
To verify resistance of BSC8_SORE+ cells to 5-fluorouracil in silico, we used Cancer Drug Resistance Navigator (CDRgator) (http://cdrgator.ewha.ac.kr, accessed on 15
September 2020). CDRgator is a database that unifies data on drug resistance gene signatures for about 1000 cancer cell lines and cancer cells of resistant patients (for about
30 drugs).
4.5. Cell Proliferation and Colony Formation Assaying
We seeded the cells into a 96-well plate at 0.5 × 104 cells/well with a complete medium
at 37 ◦ C. To determine the number of live cells, we added the methylthiazolyldiphenyltetrazolium bromide (MTT) reagent to each well in 0, 24, 48, 72, and 96 h, respectively. The
absorbance at 570 nm was detected spectrometricaly with a microplate reader (Bio-Rad
Laboratories, Hercules, CA, USA). To determine clonogenic ability, we seeded the cells into
a 24-well plate in the amount of 200 cells/mL in five repetitions and incubated them for
14 days. Then we stained the cell colonies with 0.01% crystal violet and counted them.
4.6. Soft Agar Cloning
Cells were counted, resuspended at 2 × 103 cells/mL in the medium (DMEM with
10% FBS and L-glutamine) containing 0.3% weight/volume (w/v) agar (Bacto, Dickinson,
Sparks, MD, USA) and overlaid onto a 30-mm dish containing a solidified bottom layer of
0.6% w/v agar in the same medium. After incubation for 10–15 days at 37 ◦ C and 10% CO2 ,
all dishes were stained by adding 1 mL/dish of 0.01% (w/v) crystal violet (Fronine, Taren
Point, NSW, Australia), and the colonies were counted with a dissection microscope. The
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assaying was triplicate. The role of cultivation under hypoxic conditions was analyzed in
hypoxia incubation chamber (StemcellTechnologies, Vancouver, British Columbia, Canada)
with certified medical grade pre-mixed gas (1% O2 , 5% CO2 , 94% N2 ).
4.7. Wound Repair Assay
Cells were plated in 24-well plates at 106 cells/well in 1 mL of the culture medium.
Two days later, a wound was scratched in the adherent cell monolayers with an Eppendorf
tip, and the medium was changed to DMEM supplemented with 1% FBS (Invitrogen,
Thermo Fisher Scientific; Waltham, MA, USA). We examined the wells every day and
took the photomicrographs using the EVOS FL Auto Imaging System (Invitrogen, Thermo
Fisher Scientific; Waltham, MA, USA). Then we measured the wound width on the photomicrographs using the same well area for each measurement.
4.8. Migration Assay
For migration assaying, we used Transwell chambers (Corning Product; Corning, NY,
USA) equipped with 8-µm-pore inserts. We plated the cells in serum-free medium on
uncoated inserts and incubated them for 48 h. The volume of 600 µL of culture medium
containing 20% FBS (Invitrogen, Thermo Fisher Scientific; Waltham, MA, USA) was added
to the lower chamber. We removed non-invaded cells and fixed the cells attached to the
bottom of the membrane with 4% paraformaldehyde, stained them with 5% crystal violet
(Sigma-Aldrich Co., St. Louis, MO, USA) and counted at 200× magnification. These
experiments were performed in triplicate.
4.9. Timelapse Microscopy and Confocal Imaging
Confocal imaging was performed on a Yokogawa CQ1 automated microscope. We used
green fluorescent protein (GFP, 561 nm), 40 ,6-diamidino-2-phenylindole (DAPI, 488 nm),
and phase channels. The cell nuclei were stained with Hoechst 33342 (Invitrogen, Thermo
Fisher Scientific; Waltham, MA, USA).
4.10. RNA Isolation for Transcriptome Sequencing
Total RNA was isolated from cultured cells and tissue samples (with preliminary
homogenization) using the RNeasy Mini Kit (Qiagen). RNA concentration was measured
on a NanoDrop 2000 spectrophotometer (Invitrogen, Thermo Fisher Scientific; Waltham,
MA, USA). RNA was stored at −80 ◦ C.
4.11. Transcriptome Sequencing and Analysis
NGS was done on the Illumina platform by parallel measurement of three biological
samples both for BSC8_SORE+ and control cells with a read length of 150 nm. The NGS
reads were processed similarly to the previous work [147]. The reads were trimmed using
Trimmomatic software with default parameters [148]. The trimmed reads were mapped to
the canonical nonredundant human transcriptome presented in the RefSeq database [149]
using the Bowtie 2 software [150]. This aligner became a de facto standard within mapping
pipelines showing a remarkable tolerance both to sequencing errors and indels [151].
We analyzed the resulting gene counts using the Limma package (implemented in the
R environment) specially developed for whole transcriptome analyses of differentially
expressed genes [152]. The extended version of the transcriptome analysis is presented in
Supplementary Methods.
4.12. Gene Module Analysis
The gene module enrichment analysis was similar to the previous work [153–156].
The biological processes were taken from the GO database [157]. As a source of molecular
pathways, we used the NCBI BioSystems [158]. The redundancy of this resource, which
is a most complete compendium of molecular pathways from different databases, was
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eliminated by uniting entries with identical gene sets. The extended method is presented
in Supplementary Methods.
4.13. Protein-Protein Interaction Network Analysis
The protein-protein interactions (PPI) were taken from the STRING database [159].
The PPI networks (PINs) were visualized using the STRING server. We analyzed the
dense connected components of PINs for proteins encoded by genes differing in expression
between BSC8_SORE+ cells and the control BSC8cell line, as previously [160–166]. Gene
expression difference for genes in the network was not less than ten folds.
The up-regulated and down-regulated genes were analyzed separately.
4.14. Intrinsic Disorder Predisposition Analysis
We analyzed the intrinsic disorder predisposition in 219 induced and 175 inhibited
proteins using a set of specialized computational tools. The global disorder propensity of
target proteins (i.e., their classification as wholly ordered or wholly disordered) was evaluated by the charge hydrophathy—cumulative distribution function (CH-CDF) analysis.
The CH-plot classifies query proteins as proteins with substantial amounts of extended
disorder (native coils and native pre-molten globules) or proteins with compact globular
conformations (native molten globules and ordered proteins) using information on their
absolute mean net charge and mean hydropathy [167,168]. The CDF plot discriminates all
types of disorder (native coils, native molten globules, and native pre-molten globules)
from the ordered proteins [168]. Therefore, the combined CH-CDF plot (where Y-coordinate
of a query protein is its distance from the boundary in the CH-plot and X-coordinate is an
average distance of its CDF curve from the CDF boundary) gives an opportunity for unique
assessment of intrinsic disorder in several categories, allowing predictive classification of
proteins into structurally different classes [69–72]. In fact, based on their positions within
the CH-CDF phase space plot, the query proteins are classified as ordered proteins (i.e.,
those predicted as ordered and compact by both CDF and CH; these are located within the
lower-right quadrant (Q1), native molten globules or hybrid proteins containing sizable
levels of order and disorder (i.e., proteins predicted to be disordered by CDF but compact
by CH-plot that can be found within the lower-left quadrant (Q2), proteins with extended
disorder, such as native coils and native pre-molten globules (i.e., proteins predicted to be
disordered by both methods that are located within the upper-left quadrant (Q3), and proteins predicted to be disordered by CH-plot but ordered by CDF (the upper-right quadrant
(Q4) [71].
Per-residue disorder predisposition of query proteins was evaluated using a set of
disorder predictors from the PONDR family PONDR® VLXT [169], PONDR® VL3 [170],
PONDR® VSL2 [171] and PONDR® FIT [172], as well as IUPred computational platform
that allows identification of either short or long regions of intrinsic disorder, IUPred-L and
IUPred-S [173,174]. The use multiple computational tools for prediction of intrinsic disorder
in proteins is an accepted practice in the field. This is because different computational
tools use different attributes (such as amino acid composition, hydropathy, sequence
complexity, etc.) and models for to calculate a disorder predisposition score for every
amino acid residue in a query protein. As a result, often, different tools generate rather
different outputs. There is no accepted consensus, of which disorder predictor is the
best in evaluating disorder predisposition of a query protein. In reality, since different
computational tools are sensitive to different disorder-related aspects of the amino acid
sequence, all of them contain some useful information.
The per-residue disorder predisposition scores are on a scale from 0 to 1, where values
of 0 indicate fully-ordered residues, and values of 1 indicate fully-disordered residues.
Values above the threshold of 0.5 are considered disordered residues, whereas the residues
with the disorder scores between 0.25 and 0.5 are considered as highly flexible, and the
residues with the disorder scores between 0.15 and 0.25 are classifies as flexible. The
results of these analyses were used to classify query proteins based on their percent of

Int. J. Mol. Sci. 2021, 22, 4682

22 of 29

predicted intrinsically disordered residues (PPIDR) and mean disorder score (MDS). Here,
the accepted strategy was used to classify proteins based on their PPIDR values as highly
ordered (PPIDR < 10%), moderately disordered (10% ≤ MDS < 30%), and highly disordered
(PPIDR ≥ 30%) [175]. Similarly, proteins were considered as highly ordered, moderately
disordered, and highly disordered if their MDS values were MDS < 0.25, 0.25 ≤ MDS < 0.5,
and MDS ≥ 0.5, respectively.
4.15. Statistical Evaluation
RNA levels and cell viability were evaluated after three identical tests. Statistical
difference in the analysis of variance was calculated using Statistica 6.0, with differences
with p < 0.05 being considered as statistically significant. Mixed-model analysis of variance
(ANOVA) or the Student’s t-test was used to analyze data from the luciferase reporter
assays, and p values less than 0.05 were considered as statistically significant.
5. Conclusions
Achieving a significant success in the treatment of malignant tumors is impossible
without effective targeting of the stem cells. It is necessary to target genes that provide
unlimited proliferation and self-renewal of the stem component. The use of reporter
constructs detecting the expression level of these factors as an enrichment method allows
visualization and analysis of the most malignant subpopulation of tumor cells.
The use of the lentiviral reporter made it possible to isolate a high-malignant subpopulation of colon adenocarcinoma cancer cells. A comparative analysis of the transcriptome
of stem-like cells allowed to characterize the main signaling pathways involved in their
self-maintenance and proliferation. The results of this analysis can serve as further evidence
of the high similarity of the CSC early embryonic development and functioning processes.
Reversing of the stem phenotype towards terminal differentiation is a promising direction
in cancer treatment. The transcriptome analysis revealed a set of genes that can serve as
potential prognostic markers and therapeutic targets in colon adenocarcinoma treatment.
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